Thomas Crede

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

Andrew Boulle, Mary‐Ann Davies, Hannah Hussey et al. · Clinical Infectious Diseases · 2020 · 598 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +17

Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa

Susan Meiring, Stefano Tempia, Jinal N. Bhiman et al. · Clinical Infectious Diseases · 2022 · 65 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Diagnostics +13

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial

Angharad Davis, Sean Wasserman, Cari Stek et al. · Clinical Infectious Diseases · 2022 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial

Sean Wasserman, Angharad Davis, Cari Stek et al. · Antimicrobial Agents and Chemotherapy · 2021 · 40 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)

Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen et al. · Scientific Reports · 2022 · 33 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15